It also delays gastric emptying, inhibits glucagon release from pancreatic alpha cells, causes the proliferation of beta cells, and decreases their apoptosis
This echoes the clinical practice already emerging with semaglutide and tirzepatide, where some prescribers step patients down after target weight is achieved
Throughout your time with us, we monitor your labs and vital signs to verify your body is handling the medication safely
Facing high rates of type 2 diabetes and obesity, the Kingdom is leveraging a strong need to localize drug production, build life sciences infrastructure, and establish itself as a regional biotech hub
Reducing food cravings and food noise
Among the rare ocular side effects of GLP-1RAs is non-arteritic anterior ischemic optic neuropathy (NAION), which can cause permanent loss of vision, states the report, Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice. The report was first presented at the 2025 Optometry's Meeting | 5th World Congress of Optometry and is meant to provide critical guidance to doctors of optometry treating patients on GLP-1RAs
